Data are within the paper and available on GEO with accession number: GSE79327.

Introduction {#sec001}
============

Soy-seed-derived products and their nutritional quality are affected by the subunit composition of seed storage proteins \[[@pone.0159723.ref001]--[@pone.0159723.ref004]\]. Glycinin (11S globulin) and β-conglycinin (7S) are the two main proteins in soybean seeds, accounting for \~70% of total seed proteins. By manipulating the identified variant alleles of glycinin and β-conglycinin, it is possible to breed soybean varieties with modified protein compositions, ranging from extremely high to extremely low 11S:7S ratios, which have led to improved nutritional values and food-processing properties \[[@pone.0159723.ref001],[@pone.0159723.ref005]--[@pone.0159723.ref006]\]. In the past three decades, efforts to develop 7S-low-type soybean lines have led to the availability of various 7S or 11S globulin protein subunit null varieties among soybean germplasms \[[@pone.0159723.ref001],[@pone.0159723.ref007]--[@pone.0159723.ref012]\]. Despite the deficiency of 7S and 11S major protein subunits, the nitrogen content of the mutant dry seeds is similar to (or higher than) wild-type cultivars, and most mutants grow and reproduce normally \[[@pone.0159723.ref002]\]. Specifically, β-conglycinin allergen-subunit-deficiency mutants have high nutritional value and low allergenic risk \[[@pone.0159723.ref001],[@pone.0159723.ref005]--[@pone.0159723.ref006],[@pone.0159723.ref013]--[@pone.0159723.ref014]\].

β-Conglycinin is the major seed protein of soybean (*Glycine max* (L.) Merr.), and comprises three subunits: α′ (76 kDa), α (72 kDa), and β (52 kDa) in varying proportion \[[@pone.0159723.ref015]\]. β-Conglycinin contains lower amounts of sulfur-containing amino acids and has a reduced gel-forming ability than glycinin \[[@pone.0159723.ref016]\]. Specifically, the α and α′-subunits of β-conglycinin negatively influence the nutrition of seed proteins and the gelation of tofu \[[@pone.0159723.ref001],[@pone.0159723.ref005],[@pone.0159723.ref012],[@pone.0159723.ref017]\]. In addition, the three subunits are major allergens \[[@pone.0159723.ref005],[@pone.0159723.ref017]--[@pone.0159723.ref020]\]. Genetic studies demonstrated that the absence of the α-subunit is controlled by a single recessive α-null allele, *cgy-2* \[[@pone.0159723.ref021]--[@pone.0159723.ref023]\]. Gene symbols *Cgy2*/*cgy2* were proposed for the genes that confer the presence or absence of the α-subunit of soybean β-conglycinin \[[@pone.0159723.ref021]--[@pone.0159723.ref022]\]. To date, the genetic effect of the α-null mutation and the molecular mechanism of *cgy-2* allele variation remain unclear.

The transcriptome corresponding to most of the protein coding genes is a small but important representation of the genome. Recently, RNA sequencing (RNA-seq) technologies have been developed that offer an opportunity to deliver fast, cost-effective, and accurate means to analyze the transcriptome in non-model organisms. With advances in RNA-seq, a large number of molecular markers and transcripts involved in specific biological processes could be identified. In soybean, transcriptome analyses of gene expression profiles during soybean seed development have been conducted mainly using microarray analysis and RNA-seq technology \[[@pone.0159723.ref024]--[@pone.0159723.ref027]\]. By utilizing DNA microarray analysis, Narikawa et al. \[[@pone.0159723.ref024]\] verified the changes in seed metabolism in the glycinin-null cultivar Tousan 205. Tousan 205 exhibited higher expression levels of stress-related genes, such as ascorbate peroxidase, than its parent cultivar 'Tamahomare'. Their results suggested that the deficiency of glycinin caused an expression change of stress-related genes.

In contrast to the *Cgy-2* allele (conferring α-normal), information on the *cgy-2* allele (conferring α-null) is limited. In the present study, we have examined the effect of *cgy-2* allele on the amino acid composition and gene expression. The information generated from this study will be valuable to soybean breeders involved in the modification of soybean seed protein composition.

Materials and Methods {#sec002}
=====================

Plant materials {#sec003}
---------------

Near-isogenic line (NIL) *cgy-2-*NIL, carrying the *cyg-2* allele (conferring α-null) ([Fig 1](#pone.0159723.g001){ref-type="fig"}), used for this study were derived from an α-subunit-null population, which has previously been used by our group to develop α-subunit-null improved lines with a Chinese soybean genetic background \[[@pone.0159723.ref012]\].

![(A) Breeding process of the '*cgy-2-*NIL'. RPGR = recurrent parent genome recovery. Discontinuous lines link the last generation where the definitive near isogenic lines (NILs) were selected. Numbers alongside discontinuous lines show how many lines were obtained in each candidate line. (B) Graphical genotype for chromosome 20 in '*cgy-2-*NIL' with the 'DN47' genetic background. (C) SDS-PAGE analysis of mature seed proteins of DN47 and four *cgy-2-*NIL lines: B-12088-3, B-12088-6, B-12088-8, and B-12088-12. (D) Immunoblot analysis of the seed extracts shown in (C) using antibodies specific for β-conglycinin subunits. The sizes of the protein markers (M) in kilodaltons are shown on the left of the image in (C). The arrows point to the α′, α, and β-subunits of β-conglycinin in Fig (C) and (D).](pone.0159723.g001){#pone.0159723.g001}

About 45 days after sowing, fully expanded flowers were marked individually with a tag at the 4^th^, 5^th^, 6^th^, or 7^th^ nodes on *cgy-2*-NIL and DN47 ([Fig 2A](#pone.0159723.g002){ref-type="fig"}). Pod samples were collected during seed development at 15, 18, 20, 25, 30, 35, 40, 45, 50, 55, and 60 days after flowering (DAF, [Fig 2B](#pone.0159723.g002){ref-type="fig"}) during the summer of 2014. All seed samples (BC~4~F~5~) (combined cotyledon and seed coat) of a given age were pooled and stored at −80°C for future use ([Fig 2C](#pone.0159723.g002){ref-type="fig"}). Unusual-sized seeds were excluded from the soybean samples. Based on the assessment of the different expressions of the α-subunit gene between the *cgy-2-*NIL and DN47 by quantitative real-time reverse transcription PCR (qRT-PCR) ([Fig 2D](#pone.0159723.g002){ref-type="fig"}), five stages of soybean seeds collected at 18, 25, 35, 50, and 55 DAF were finally selected for RNA-seq analysis.

![(A) Fully expanded flowers were marked individually with a tag at the 4^th^, 5^th^, 6^th^, or 7^th^ nodes on *cgy-2*-NIL and DN47. (B) Pod samples were collected during seed development at 15, 18, 20, 25, 30, 35, 40, 45, 50, 55, and 60 days after flowering (DAF). (C) Developmental changes in morphology, size, and weight of sampled seeds in *cgy-2*-NIL and DN47. (D) Comparison of transcript levels of the α-subunit gene between *cgy-2*-NIL and DN47. Differential expression of more than 50-fold was identified during the 25--55 days after flowering (DAF) development stages. Five stages of soybean seeds collected at 18, 25, 35, 50, and 55 DAF were finally selected to subjected to RNA-seq.](pone.0159723.g002){#pone.0159723.g002}

SDS-PAGE and immunoblot analysis {#sec004}
--------------------------------

Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot analysis were performed as described earlier \[[@pone.0159723.ref020], [@pone.0159723.ref028]\]. Briefly, total seed proteins (25 μg) from DN47 and *cgy-2*-NIL lines were resolved on 10% polyacrylamide gels. Separated proteins were visualized by staining with Coomassie brilliant blue or electrophoretically transferred to a nitrocellulose membrane and incubated with polyclonal antibodies raised against the α-subunit of β-conglycinin. Immunoreactive proteins were detected using an anti-rabbit IgG-horseradish peroxidase conjugate followed by chemiluminescent detection.

Determination of seed protein content and amino acid analysis of '*cgy-2*-NILs' {#sec005}
-------------------------------------------------------------------------------

Dry seeds of DN47 and *cgy-2*-NIL were harvested at maturity in 2014 and stored at room temperature. Ten plants of each *cgy-2-*NIL and DN47 were examined. Total seed nitrogen was measured using the Micro-Kjeldahl method (Foss, 2300 Kjeltec Analyzer Unit). The crude protein content was determined by calculating the nitrogen content and then multiplying the result by a conversion factor of 6.25.

Total amino acids (AAs) were obtained from hydrolysis of seed meal in 6 M HCl for 22 h in sealed evacuated tubes at a constant boiling temperature of 110°C. An amino acid analyzer (Hitachi L-8800; Hitachi, Tokyo, Japan) was used to determine the AA composition of the hydrolysates.

Free AAs were extracted from 5.00 g of seed meal. Seed meal (seeds were sampled using a sample quartiles method, fully dried with mill grinding through a 0.25-mm sieve, and thoroughly mixed) was finely homogenized in 30 mL of sulfosalicylic acid (10 g per 100 mL) and disrupted ultrasonically for 30 min. The supernatant was centrifuged at 5000 × *g* for 5 min. The resultant supernatant was filtered through a 22-μm GD/X sterile disposable syringe filter. A Hitachi L-8800 amino acid analyzer was then used to analyze the filtrate.

The amino acid quality was compared between *cgy-2-*NIL and DN47 using a scoring method. The amino acid score (AAS) was calculated according to the scoring pattern suggested by the Food and Agriculture Organization and World Health Organization (FAO/WHO) \[[@pone.0159723.ref029]\]. Concentration was expressed as grams of amino acid/16 gN in the test protein divided by grams of amino acid/16 gN in the scoring pattern. Each data set and reference patterns were also used to calculate EAAI (essential amino acid index) \[[@pone.0159723.ref030], [@pone.0159723.ref031]\]. The EAAI is the geometric mean of the individual amino acid scores and is equal to the antilogarithm of the individual scores. The AAS was calculated using the following formula: $${Amino\ acid\ score} = \frac{{mg\ of\ amino\ acid\ in}\ 1\ {g\ of\ test\ protein}}{{mg\ of\ amino\ acid\ in}\ 1\ {g\ reference\ pattern}} \times 100$$

The EAAI values were assigned a maximum of 1.00 and a minimum of 0.01. Feedstuffs are rated as good-quality protein sources when the EAAI is ≥ 0.90, adequate when approximately 0.80, and inadequate below 0.70 \[[@pone.0159723.ref032]\].

RNA isolation, cDNA library construction, and Illumina deep sequencing {#sec006}
----------------------------------------------------------------------

Seed samples harvested at five growth stages corresponding to 18, 25, 35, 50, and 55 DAF from DN47 and *cgy-2*-NIL in the summer of 2014 were used for RNA-seq analysis. Two individual biological replicates were tested for the five developmental stages, resulting in 20 samples. In order to minimize biological variation, RNA from separate biological samples was used for the two biological replicates per stage, the values of correlation coefficient (R^2^ value) of all DEGs for each 2 biological replicates ranged from 0.961 to 0.992. All of the samples were stored in liquid nitrogen immediately after collection in the field and then transported to a −80°C freezer in our laboratory at the Northeast Agriculture University soybean research center.

Total RNA was extracted from each sample using the improved cetyl trimethylammonium bromide method \[[@pone.0159723.ref033]\]. RNA degradation and contamination was monitored on 1% agarose gels. A NanoPhotometer spectrophotometer (Implen, CA, USA) was used to check the RNA purity. A Qubit RNA Assay Kit in a Qubit 2.0 Fluorometer (Life Technologies, CA, USA) was used to measure the RNA concentration and an RNA Nano 6000 Assay Kit of the Bioanalyzer 2100 system (Agilent Technologies, CA, USA) was utilized to assess the RNA integrity. All RNA samples had RNA integrity number (RIN) values above 6.5.

mRNA was extracted using Dynabeads oligo (dT) (Dynal; Invitrogen). Double-stranded cDNAs were synthesized using reverse transcriptase (Superscript II; Invitrogen) and random hexamer primers. To select preferentially cDNA fragments of 200 bp in length, the library fragments were purified using the AMPure XP system (Beckman Coulter, Beverly, CA, USA). DNA fragments with ligated adaptor molecules on both ends were enriched selectively using the Illumina PCR Primer Cocktail in a 10-cycle PCR reaction. Products were purified using the AMPure XP system and quantified using the Agilent high-sensitivity DNA assay on the Agilent Bioanalyzer 2100 system. cDNA Library concentration was first quantified using a Qubit 2.0 fluorometer (Life Technologies), and then diluted to 1 ng/μl before checking insert size on an Agilent 2100 and quantifying to greater accuracy by quantitative PCR (Q-PCR) (library activity \>2 nM).The library preparations were sequenced on an Illumina Hiseq 2000 platform and 100-bp paired-end reads were generated. Illumina sequencing was performed by Novogene Bioinformatics Technology Co., Ltd., Beijing, China ([www.novogene.cn](http://www.novogene.cn/)).

Bioinformatic analysis of differentially expressed genes (DEGs) {#sec007}
---------------------------------------------------------------

To obtain high-quality clean reads, raw data (raw reads) in fastq format were first processed using in-house Perl scripts. The calculation of Q20, Q30, GC-content, and all the downstream analyses were based on the high-quality clean data. The reference genome (<ftp://ftp.ensemblgenomes.org/pub/release-23/plants/fasta/glycine_max/>) and gene model annotation files were downloaded from the genome website directly. We used HTSeq v 0.6.1 ([www-huber.embl.de/users/anders/HTSeq/](http://www-huber.embl.de/users/anders/HTSeq/)) to count the read numbers mapped to each gene. Data were then provided in reads per kilobase per million reads (RPKMs) \[[@pone.0159723.ref034]\]. Differential expression analysis was performed using the DESeqR package (1.10.1) \[[@pone.0159723.ref035]\]. P-values were adjusted using the Benjamini and Hochberg approach; with a P-value \< 0.05 being used as the threshold for significant differential expression. Gene Ontology (GO) (<http://www.geneontology.org/>) analysis was performed by the GOseq R package \[[@pone.0159723.ref036]\], and GO terms with corrected P-values \< 0.05 were considered significantly enriched for the DEGs. We used KOBAS software (KOBAS, Surrey, UK) to test the statistical enrichment of DEGs in KEGG pathways (<http://www.kegg.jp/kegg/pathway.html>). Datasets were deposited in the GEO (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=qpwjwcsqjhahzed&acc=GSE79327>) with accession number GSE79327.

qRT-PCR confirmation of the Illumina sequencing data {#sec008}
----------------------------------------------------

RNA-seq data were further validated using qRT-PCR for six selected genes, using gene-specific primer sets ([Fig 3A](#pone.0159723.g003){ref-type="fig"}). Primer pairs were designed using the Primer 5 software. Actin was amplified along with the target gene as an endogenous control to normalize expression between different samples. qRT-PCR was performed using a real-time RT-PCR kit (Takara, Japan), on a CFX96 Real-Time System (BioRad, USA). The delta-delta-cycle threshold (Ct) method was used to calculate the relative expression of each mRNA \[[@pone.0159723.ref037]\].

![(A) Primer sequences used in quantitative real-time reverse transcription PCR (qRT-PCR) analysis for validation of the expressed genes in Illumina sequencing. (B) Comparison between the gene expression ratios obtained from RNA-seq data and that from qRT-PCR. The RNA-seq log2 value of the expression ratio (y-axis) was plotted against the developmental stages (x-axis). (C) qRT-PCR analysis of differentially expressed genes between *cgy-2*-NIL and DN47. The transcript abundance from the RNA-seq data is shown at the top of the panel for each gene. RPKM: reads per kilobase per million reads. DAF = days after flowering.](pone.0159723.g003){#pone.0159723.g003}

Results {#sec009}
=======

Phenotype screening for α-subunit nulls using SDS-PAGE and immunoblot analysis {#sec010}
------------------------------------------------------------------------------

The *cgy-2-*NILs were derived as outlined in [Fig 1A](#pone.0159723.g001){ref-type="fig"}. In the BC~3~F~2~ population \[[@pone.0159723.ref012]\], three individuals, B12038, B12040, and B12088, with recurrent parent genome recoveries of 98.47%, 98.98%, and 99.49%, respectively, were selected as α-null donor parents. BC~4~F~2~ progeny derived from these selected BC~3~F~2~ parents with the homozygous *cgy-2* gene, were selfed to obtain 69 BC~4~F~3:4~ individuals, which were designated as *pre-ILs*, including three sets: 24 lines for B12038, 19 lines for B12040, and 26 lines for B12088 ([Fig 1A](#pone.0159723.g001){ref-type="fig"}). These *pre-ILs* were genotyped again using polymorphic molecular markers for verification. Uniformity regarding plant type was also examined within each line. Seventeen lines containing only a single introgression in chromosome 20 containing the *cgy-2* gene in B12088 progeny were obtained ([Fig 1B](#pone.0159723.g001){ref-type="fig"}). Combined with stringent phenotypic selection, a final collection of four ideal NILs was obtained, with each NIL containing the *cgy-2* allele (hereafter named '*cgy-2-*NIL') ([Fig 1A](#pone.0159723.g001){ref-type="fig"}). BC~4~F~5~ seeds obtained in 2014 from the above experiments were used for all subsequent experiments in this study. The recurrent parent DongNong 47 (DN47), containing all storage protein subunits, was used as the control ([Fig 1C](#pone.0159723.g001){ref-type="fig"}, lane 1). *cgy-2-*NIL only differed from the DN47 control by its introgressed donor DNA fragment containing the *cgy-2* gene ([Fig 1B](#pone.0159723.g001){ref-type="fig"}). Therefore, any observable phenotypic differences are expected to be a result of the *cgy-2* gene.

The absence α-subunit of β-conglycinin in the developed *cgy-2-*NIL was verified by SDS-PAGE ([Fig 1C](#pone.0159723.g001){ref-type="fig"}) and immunoblot analysis ([Fig 1D](#pone.0159723.g001){ref-type="fig"}). An examination of the total seed protein profile of DN47 revealed the presence of all three subunits of β-conglycinin ([Fig 1C](#pone.0159723.g001){ref-type="fig"}). In contrast, the *cgy-2*-NILs (12088--3, 12088--6, 12088--8, and 12088--12) failed to accumulate the 72-kDa α subunit of β-conglycinin ([Fig 1C](#pone.0159723.g001){ref-type="fig"}). This observation was further confirmed by western blot analysis ([Fig 1D](#pone.0159723.g001){ref-type="fig"}). β-conglycinin-specific antibodies recognized all the three subunits of β-conglycinin from DN47, while the *cgy-2*-NILs showed no reactivity against the 72-kDa α subunit of β-conglycinin. This observation confirms that the α subunit of β-conglycinin is absent in the *cgy-2*-NILs.

Effect of allelic variation of the α-subunit locus on soybean amino acid composition {#sec011}
------------------------------------------------------------------------------------

To understand the effect of allergen-α-subunit-deficiency on soybean amino acids (AAs) composition, the AA content and nutritional quality were investigated. The crude protein content, AA concentration, and free amino acids (FAA) concentrations of the homozygous *cgy-2*-NIL and the recurrent parent DN47 were compared. In *cgy-2-*NIL compared with DN47, there was a 4.11%, 4.16%, 5.20%, and 11.96% increase in crude protein content, total AA content, total essential amino acid (TEAA) content, and sulfur-containing (Met and Cys) content, respectively ([Table 1](#pone.0159723.t001){ref-type="table"}). The concentration of Thr, Val, Met, and Ile increased significantly in *cgy-2-*NIL, resulting in a significant increase in TEAA content. The sulfur-containing (Met and Cys) AA concentration increased significantly in *cgy-2-*NIL. The total AA concentration also increased in *cgy-2-*NIL because of the general increase in constituent content of most AAs ([Table 1](#pone.0159723.t001){ref-type="table"}).

10.1371/journal.pone.0159723.t001

###### Comparison of amino acid and free amino acid contents of mature seeds between 'DN47' and its near-isogenic line,'*cgy-2* NIL'.

![](pone.0159723.t001){#pone.0159723.t001g}

                              A.A.           F.A.A.                             
  --------------------------- -------------- ---------------- ----------------- -------------------
  Essential amino acids                                                         
  Thr                         1.38 ± 0.09    1.54 ± 0.03\*    0.2127 ± 0.0115   0.2783 ± 0.0084\*
  Val                         1.48 ± 0.04    1.55 ± 0.02\*    0.1007 ± 0.0167   0.1043 ± 0.0032
  Met                         0.40 ± 0.06    0.52 ± 0.01\*    0.0660 ± 0.0035   0.0840 ± 0.0010\*
  Ile                         1.48 ± 0.06    1.58 ± 0.02\*    0.0720 ± 0.0069   0.0707 ± 0.0029
  Leu                         2.71 ± 0.05    2.80 ± 0.04      0.1133 ± 0.0098   0.1510 ± 0.0046\*
  Phe                         1.80 ± 0.04    1.79 ± 0.03      0.1480 ± 0.0017   0.1677 ± 0.0025\*
  Lys                         2.29 ± 0.03    2.36 ± 0.04      0.2287 ± 0.0271   0.2537 ± 0.0012
  T.E.A.A.                    11.53 ± 0.24   12.13 ± 0.16\*   0.9413 ± 0.0577   1.1097 ± 0.0015\*
  Non-essential amino acids                                                     
  Asp                         3.85 ± 0.12    4.06 ± 0.04\*    0.7033 ± 0.0046   0.6263 ± 0.0381\*
  Ser                         1.81 ± 0.06    1.90 ± 0.02      0.0825 ± 0.0009   0.1133 ± 0.0068\*
  Glu                         5.93 ± 0.13    5.87 ± 0.04      0.5113 ± 0.0144   0.5020 ± 0.0156
  Gly                         1.45 ± 0.02    1.53 ± 0.03\*    0.0633 ± 0.0058   0.0913 ± 0.0006\*
  Ala                         1.47 ± 0.03    1.58 ± 0.02\*    0.0940 ± 0.0052   0.1663 ± 0.0045\*
  Cys                         0.52 ± 0.01    0.51 ± 0.01      0.1873 ± 0.0023   0.1797 ± 0.0075
  Tyr                         1.14 ± 0.03    1.19 ± 0.03      0.0873 ± 0.0023   0.1220 ± 0.0070\*
  His                         0.89 ± 0.02    0.99 ± 0.01\*    0.1367 ± 0.0289   0.2873 ± 0.0452\*
  Arg                         2.36 ± 0.08    2.58 ± 0.02\*    0.7547 ± 0.0214   1.9817 ± 0.3537\*
  Pro                         1.77 ± 0.07    1.75 ± 0.02      0.1450 ± 0.0364   0.2043 ± 0.0015\*
  T.A.A                       32.72 ± 0.41   34.08 ± 0.37\*   3.7128 ± 0.0673   5.3837 ± 0.4481\*
  T.S.A.A.                    0.92 ± 0.05    1.03 ± 0.01\*    0.2533 ± 0.0058   0.2637 ± 0.0065
  Protein                     37.96 ± 0.39   39.52 ± 0.28\*                     

Data are means ± SD for seeds from at least three plants. Asterisks indicate statistically significant differences (\*P \< 0.05) between 'DN47' and 'NIL-DN47-Δα'. Each amino acid is expressed using its three-letter abbreviation.

A.A.: amino acid; FAA: free amino acid; NIL: near-isogenic line'; T.A.A.: total amino acids; T.S.A.A: total sulfur-containing amino acids (Met+Cys).

The increased content of FAAs in *cgy-2-*NIL was most pronounced for Arg, which increased by more than two-fold compared with DN47 ([Table 1](#pone.0159723.t001){ref-type="table"}). In *cgy-2-*NIL, Arg comprised 36.81% of FAAs, with Asp and Glu providing a further 11.63% and 9.32%, respectively; the remaining 42.24% comprised various other FAAs. His concentration also increased by two-fold in *cgy-2-*NIL; however, its content was much lower than Arg. The general and significant increase in the constituent content of most FAAs resulted in a significant increase in the total essential FAA and total FAA contents ([Table 1](#pone.0159723.t001){ref-type="table"}).

The amino acid score was calculated according to the scoring pattern suggested by the FAO/WHO \[[@pone.0159723.ref029]\]. Both the total EAA content and the EAAI of *cgy-2-*NIL were higher than that of DN47 ([Table 2](#pone.0159723.t002){ref-type="table"}). Our results suggested that the null allele of α-subunit positively affected the AA scores.

10.1371/journal.pone.0159723.t002

###### Amino acid (A.A.) profile of mature seeds in 'DN47' and its near-isogenic line, '*cgy-2* NIL'.

![](pone.0159723.t002){#pone.0159723.t002g}

  A.A.                        FAOmg/gPro.   D47                NIL (α-null)            
  --------------------------- ------------- ------------------ -------------- -------- --------
  Essential amino acids                                                                
  Thr                         40            36.27              90.67          38.88    97.21
  Val                         50            38.90              77.80          39.30    78.61
  Met+Cys                     35            24.15              68.99          25.98    74.22
  Ile                         40            38.90              97.25          39.98    99.95
  Leu                         70            71.39              101.99         70.85    101.21
  Phe+Tyr                     60            77.45              129.08         75.40    125.67
  Lys                         55            60.33              109.68         59.63    108.42
  Trp                         10            -Not determined-                           
  TEAA                        360           347.38                            350.03   
  EAAI(%)                     100           79.25                             82.16    
  Non-essential amino acids                                                            
  Asp                                       101.42                            102.73   
  Ser                                       47.68                             48.08    
  Glu                                       156.13                            148.45   
  Gly                                       38.29                             38.63    
  Ala                                       38.64                             39.90    
  His                                       23.53                             25.13    
  Arg                                       62.08                             65.20    
  Pro                                       46.72                             44.28    
  TAA                                       861.87                            862.43   

Data are expressed as means of triplicate experiments. Each amino acid is expressed using the three-letter code. A.A.: amino acid; Pro.: protein; A.A. Sco.: amino acid score; TEAA: total essential amino acids; EAAI: essential amino acid index; NIL: near-isogenic line *cgy*-2-NIL; TAA: total amino acids.

DEGs between '*cgy-2-*NIL' and 'DN47' {#sec012}
-------------------------------------

One of the primary goals of transcriptome sequencing is to compare the gene expression levels in two genotypes. A P-value \< 0.05 and log2 (fold change) \> 2 were used as the thresholds to judge the significant differences (enriched or depleted) in the gene expression profiles between *cgy-2-*NIL and DN47 at the same stage. Using these criteria, 20,295 DEGs were identified, which could be subdivided into 174, 151, 123, 158, and 2837 genes that varied in abundance at 18, 25, 35, 50, and 55 DAF, respectively ([Fig 4](#pone.0159723.g004){ref-type="fig"}). In general, throughout the five seed development stages, the total number of upregulated genes was less than the number of downregulated genes ([Fig 4](#pone.0159723.g004){ref-type="fig"}). Surprisingly, the maximum number of DEGs between *cgy-2-*NIL and DN47 was observed at 55 DAF. Furthermore, different from the other three stages (18, 50, and 55 DAF), there were more upregulated DEGs than downregulated DEGs at 25 and 35 DAF.

![The number of differentially expressed genes (DEGs) between '*cgy-2*-NIL' and 'DN47' at various developmental stages (18, 25, 35, 50, and 55 days after flowering (DAF)).\
Numbers of up and downregulated genes are summarized.](pone.0159723.g004){#pone.0159723.g004}

To determine whether these gene expression profiles correlated with development stages, the RNA-seq data of the *cgy-2-*NIL and DN47 were subjected to hierarchical clustering analysis using the 'H-clust (1.10.1)' function ([Fig 5](#pone.0159723.g005){ref-type="fig"}). The samples were clustered together based on genes that showed similar expression patterns. Genes expressed at the same stage both in *cgy-2-*NIL and DN47 were clustered together in all cases. The clusters of 18 DAF and 25 DAF seeds, and 35 DAF and 50 DAF seeds were very closely positioned, respectively. The 55 DAF cluster was closest to the 35 and 50 DAF clusters, and the 18 and 25 DAF clusters were farthest from the other three clusters ([Fig 5](#pone.0159723.g005){ref-type="fig"}). The greatest changes in gene expression were seen between the 25 and 55 DAF clusters. Notably, the developmental order was broken by 55 DAF; neighboring stages did not cluster together in the same order as development.

![Cluster dendrogram of differentially expressed genes in *cgy-2* NIL and 'DN47' at five developmental stages (18, 25, 35, 50, and 55 days after flowering).](pone.0159723.g005){#pone.0159723.g005}

The comparison among different development stages between *cgy-2-*NIL and DN47 is shown in [Fig 6](#pone.0159723.g006){ref-type="fig"}. The majority of DEGs showed development-stage-specific expression. Seventeen DEGs were differentially expressed in all five stages. As shown in [Table 3](#pone.0159723.t003){ref-type="table"}, among these 17 genes, only one signal transduction response regulator gene (Glyma11g15580) was upregulated during seed development. Five DEGs (Glyma02g41810, Glyma03g02370, Glyma04g41540, Glyma09g02600, and Glyma15g06160) were downregulated during seed development. The other 12 DEGs were differentially expressed among different developmental stages in both *cgy-2-*NIL and DN47, and exhibited two different expression patterns: one group, including two RNA recognition motif domain proteins (Glyma12g01350 and Glyma12g04710), one transcription factor MYC/MYB N-terminal (Glyma11g18290,) and one Ferritin-conserved site (Glyma01g31300) were upregulated in *cgy-2-*NIL only at 18 DAF, and were then downregulated in all subsequent stages. The other group, including Glyma02g04840, Glyma08g16310, Glyma11g25660, Glyma12g13920, Glyma20g16100, and Novel 100599, were upregulated in *cgy-2-*NIL at 25 DAF and 35 DAF, and downregulated at 18, 50, and 55 DAF.

![Venn diagram showing the overlap of identified differentially expressed genes (DEGs) between 'cgy-2NIL' and 'DN47' at 18, 25, 35, 50, and 55 days after flowering.](pone.0159723.g006){#pone.0159723.g006}

10.1371/journal.pone.0159723.t003

###### Seventeen genes with altered expression between '*cgy-2* NIL' and 'DN47' across five developmental stages.
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  NO.   DEG ID          Log2-fold change   DESCRIPTION                              
  ----- --------------- ------------------ ------------- -------- -------- -------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1     GLYMA01G31300   0.791              −1.889        −1.969   −1.590   −3.658   Ferritin, conserved site\|\|Ferritin\|\|Ferritin- like di-iron domain\|\|Ferritin-related\|\|Ferritin/DPS protein domain\|\|Ferritin/ribonucleotide reductase-like
  2     GLYMA02G04840   −2.190             2.255         2.190    −4.465   −2.875   Protein of unknown function DUF241, plant
  3     GLYMA02G41810   −1.321             −1.125        −0.759   −0.989   −1.103   Regulator of chromosome condensation, RCC1\|\|Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II
  4     GLYMA03G02370   −0.632             −0.646        −1.399   −1.554   −0.826   C2 calcium-dependent membrane targeting
  5     GLYMA04G41540   −0.373             −0.886        −0.826   −0.837   −2.937   Glutamate synthase, NADH/NADPH, small subunit 1\|\|\"Glutamate synthase, alpha subunit, C-terminal\"\|\|\"Glutamate synthase, central-C\"
  6     GLYMA08G16310   −0.751             2.011         1.320    −2.468   −1.264   \-
  7     GLYMA09G02600   −0.673             −1.084        −0.929   −2.871   −3.122   Haem peroxidase, plant/fungal/bacterial\|\|Haem peroxidase\|\|Peroxidases haem-ligand binding site\|\|Plant peroxidase
  8     GLYMA11G15580   0.603              0.716         0.740    1.607    1.567    Signal transduction response regulator, receiver domain\|\|CheY-like superfamily
  9     GLYMA11G18290   0.327              −0.524        −0.584   −1.232   −1.694   Myc-type, basic helix-loop-helix (bHLH) domain\|\|Transcription factor MYC/MYB N-terminal
  10    GLYMA11G25660   −3.218             1.637         1.709    −4.280   −3.175   EF-Hand 1, calcium-binding site\|\|Calcium-binding EF-hand\|\|EF-hand-like domain
  11    GLYMA12G01350   0.272              −0.661        −0.793   −1.823   −2.004   Nucleotide-binding, alpha-beta plait\|\|\"Zinc finger, CCCH-type\"\|\|RNA recognition motif domain
  12    GLYMA12G04701   0.348              −1.217        −0.846   −1.019   −1.247   Nucleotide-binding, alpha-beta plait\|\|RNA recognition motif domain
  13    GLYMA12G13920   −2.061             1.152         1.721    −1.622   −0.980   Glutaredoxin-like, plant II\|\|Glutaredoxin\|\|Thioredoxin-like fold
  14    GLYMA15G06160   −0.371             −0.481        −0.660   −1.230   −0.774   Pseudouridine synthase, catalytic domain\|\|Dyskerin-like\|\|PUA-like domain\|\|Pseudouridine synthase II
  15    GLYMA16G07750   −1.014             −0.947        −0.793   −1.497   −1.077   \-
  16    GLYMA20G16100   −0.502             1.001         0.859    −1.231   −1.507   Development/cell death domain
  17    Novel00599      −3.625             2.378         2.300    \-       −2.038   

The top 20 genes that showed high-level differential expression related to the α-null mutation were ranked and are shown in [Table 4](#pone.0159723.t004){ref-type="table"}. Glyma17g34220 (encoding alpha crystalline) and another six genes (Glyma13g11840, Glyma13g1189, Glyma13g11961, Glyma13g12033, Novel00815, and Novel01348), which were not annotated, were all downregulated at 18 DAF. Expression of Glyma13g11840 (no annotation) was downregulated by 12.16-fold, which was the most highly downregulated of all the DEGs identified in our data. Glyma20g28660 showed the highest differential expression related to α-null at 25, 35, and 50 DAF, and was downregulated by 9.32-fold at 25 DAF, 9.49-fold at 35 DAF, and 8.8-fold at 50 DAF. At 55 DAF, two genes (Glyma06g02690 and Glyma04g02660) encoding a Gibberellin-regulated protein and two genes (Glyma10g39760 and Glyma07g40110) encoding Concanavalin A-like lectins were downregulated by 9.03-fold and 7.91-fold, and by 8.47-fold and 6.93-fold, respectively. In addition, another four genes (Novel01985, Novel02415, Glyma15g10450, and Glyma16g03600) were upregulated at 55 DAF. Expression of Glyma15g10450, encoding a protein arginine N-methyltransferase, was upregulated by 8.05-fold; and Glyma16g03600, encoding an aminotransferase that takes part in cysteine and methionine metabolism, was upregulated by 7.56-fold. We hypothesized that these genes are putativelyα-null-related transcripts. Based on obtained DEGs information and bioinformatics, we will conduct further studies focused on gene function identification of the above-mentioned DEGs.

10.1371/journal.pone.0159723.t004

###### The top 20 genes showing high-level differential expression related to the α-null mutation.
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  DEG ID          Stage(DAF)   Down/Up regulation   log2-fold change   KEGG      Description                                   
  --------------- ------------ -------------------- ------------------ --------- --------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  GLYMA13G11840   18           Down                                    −12.162                                                 \-
  GLYMA13G11895   18           Down                                    −8.0568                                                 \-
  GLYMA13G11961   18           Down                                    −7.4505                                                 
  GLYMA13G12033   18           Down                                    −9.3913                                                 \-
  GLYMA17G34220   18           Down                                    −8.145    Protein processing in endoplasmic reticulum   Alpha crystallin/Hsp20 domain\|\|HSP20-like chaperone
  Novel00815      18           Down                                    −7.0188                                                 
  Novel01348      18           Down                                    −7.7437                                                 
  GLYMA20G28660   25           Down                                    −9.32                                                   
  GLYMA20G28660   35           Down                                    −9.4945                                                 Cupin 1\|\|RmlC-like cupin domain\|\|RmlC-like jelly roll fold
  GLYMA20G28660   50           Down                                    −8.8458                                                 Cupin 1\|\|RmlC-like cupin domain\|\|RmlC-like jelly roll fold
  GLYMA15G10450   55                                Up                 8.0507                                                  Protein arginine N-methyltransferase\|\|S-adenosyl-L-methionine-dependent methyltransferase-like
  GLYMA16G03600   55                                Up                 7.5585    Cysteine and methionine metabolism            Aminotransferase, class I/class II\|\|\"Aminotransferases, class I, pyridoxal-phosphate-binding site\"\|\|\"Pyridoxal phosphate-dependent transferase, major region, subdomain 1\"
  Novel01985      55                                Up                 8.6001                                                  
  Novel02415      55                                Up                 8.0925                                                  
  GLYMA04G02660   55           Down                                    −7.914                                                  Gibberellin-regulated protein
  GLYMA06G02690   55           Down                                    −9.0289                                                 Gibberellin-regulated protein
  GLYMA07G39220   55           Down                                    −7.0642                                                 Petal formation expressed
  GLYMA07G40110   55           Down                                    −6.9337                                                 Concanavalin A-like lectin/glucanase, subgroup\|\|\"Protein kinase, ATP binding site\"\|\|\"Protein kinase, catalytic domain\"\|\|\"Serine/threonine-protein kinase, active site\"
  GLYMA10G39760   55           Down                                    −8.4718                                                 Concanavalin A-like lectin/glucanase, subgroup\|\|\"Glycoside hydrolase, family 16\"\|\|\"Glycoside hydrolase, family 16, active site\"\|\|\"Xyloglucan endo-transglycosylase, C-terminal\"
  GLYMA15G14675   55           Down                                    −7.4518                                                 \-

DEG = differentially expressed gene; DAF = days after flowering

Functional annotation and pathway assignment {#sec013}
--------------------------------------------

GO analysis was used to annotate the identified significant DEGs between *cgy-2-*NIL and DN47. Three main categories, biological process, molecular function, and cellular component, in developing seeds of *cgy-2-*NIL *vs*. DN47 at five stages (18, 25, 35, 50, and 55 DAF) are shown in [Table 5](#pone.0159723.t005){ref-type="table"}. GO category enrichment analysis (P-value \< 0.05) revealed different results in different stages. A similar GO category distribution pattern of transcripts was found at 18, 35, and 55 DAF ([Table 5](#pone.0159723.t005){ref-type="table"}). For the biological process function, eight categories were identified, and the maximum number of DEGs was associated with the term 'biosynthetic process' at 18, 35, and 55 DAF. Eleven categories were identified as 'cellular component', and the terms 'cellular component' (18.89%, 19.95%, 22.26%), 'cell' (12.48%, 13.07%, 13.01%), and 'cell part' (12.48%, 13.07%, 13.01%) were the most abundant at 18, 35, and 55 DAF, respectively. In terms of molecular function, the most abundant DEGs were involved in structural molecular activity (64.41%, 58.10%, 58.36%) and structural constituents of ribosome (35.39%, 41.90%, 41.64%) at 18, 35, and 55 DAF, respectively. However, the GO category distributions of the transcripts at 25 and 50 DAF were quite different ([Table 5](#pone.0159723.t005){ref-type="table"}). Through alignment with KEGG database, 6627 unigenes were annotated to 37 terms of GO classification at 25 DAF. Among these groups, 'various biosynthetic process' and 'regulation of various metabolic process' were dominant within the 'biological process' category. Only 'apoplast' was detected in the 'cellular component' category, and 'ion binding', 'purine ribonucleoside triphosphate binding', and 'ATP binding' were dominant in the molecular function category ([Table 5](#pone.0159723.t005){ref-type="table"}) at 25 DAF. In addition, at 50 DAF, only seven terms belonging to 'cellular component' were annotated by GO category enrichment analysis.

10.1371/journal.pone.0159723.t005

###### Summary of Gene Ontology (GO) terms for differentially expressed genes (DEGs) at different developmental stages (P \< 0.05).
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  GO terms *cgy-2NILvs*. DN47                                      DESCRIPTION                    Number of DEGs                       
  ---------------------------------------------------------------- ------------------------------ ---------------- ----- ------ ------ ------
  Biological process                                               biosynthetic process           597                    760           2399
  organic substance biosynthetic process                           577                                             727          2290   
  cellular biosynthetic process                                    572                                             715          2232   
  cellular macromolecule biosynthetic process                      474                                             579          1752   
  macromolecule biosynthetic process                               476                                             582          1764   
  gene expression                                                  455                                             550          1650   
  single-organism carbohydrate catabolic process                   27                                              163          455    
  translation                                                      158                                             145          342    
  organic cyclic compound biosynthetic process                                                    283                                  
  RNA metabolic process                                            277                                                                 
  cellular nitrogen compound biosynthetic process                  275                                                                 
  heterocycle biosynthetic process                                 274                                                                 
  aromatic compound biosynthetic process                           269                                                                 
  nucleobase-containing compound biosynthetic process              256                                                                 
  RNA biosynthetic process                                         240                                                                 
  transcription, DNA-dependent                                     232                                                                 
  regulation of metabolic process                                  225                                                                 
  regulation of cellular metabolic process                         214                                                                 
  regulation of macromolecule metabolic process                    213                                                                 
  regulation of primary metabolic process                          212                                                                 
  regulation of cellular biosynthetic process                      210                                                                 
  regulation of biosynthetic process                               210                                                                 
  regulation of macromolecule biosynthetic process                 210                                                                 
  regulation of cellular biosynthetic process                      210                                                                 
  regulation of nucleobase-containing compound metabolic process   209                                                                 
  regulation of nitrogen compound metabolic process                209                                                                 
  regulation of gene expression                                    208                                                                 
  regulation of transcription, DNA-dependent                       204                                                                 
  regulation of RNA metabolic process                              204                                                                 
  regulation of RNA biosynthetic process                           204                                                                 
  cellular component movement                                      44                                                                  
  microtubule-based process                                        41                                                                  
  microtubule-based movement                                       33                                                                  
  cellular glucan metabolic process                                22                                                                  
  glucan metabolic process                                         22                                                                  
  Cellular component                                               cellular_component             902                    1368          4164
  cell                                                             596                                             896          2435   
  cell part                                                        596                                             896          2435   
  intracellular                                                    573                                             846          2305   
  intracellular part                                               518                                             795          2143   
  intracellular organelle                                          416                                             591          1654   
  macromolecular complex                                           347                                             506          1238   
  cytoplasm                                                        294                                             399          1054   
  cytoplasmic part                                                 244                                             305          754    
  ribonucleoprotein complex                                        153                                             139          296    
  ribosome                                                         137                                             117          232    
  apoplast                                                         12                                                                  
  cellular component organization or biogenesis                                                   54                                   
  cellular component organization                                                                 49                                   
  cell morphogenesis                                                                              11                                   
  cellular component morphogenesis                                                                11                                   
  anatomical structure morphogenesis                                                              11                                   
  cellular developmental process                                                                  11                                   
  single-organism developmental process                                                           11                                   
  Molecular function                                               structural molecule activity   418                    190           164
  structural constituent of ribosome                               231                                             137          117    
  ion binding                                                                                     569                                  
  purine ribonucleoside triphosphate binding                       310                                                                 
  ATP binding                                                      296                                                                 
  cytoskeletal protein binding                                     59                                                                  
  tubulin binding                                                  43                                                                  
  microtubule binding                                              42                                                                  
  motor activity                                                   41                                                                  
  microtubule motor activity                                       33                                                                  
  xyloglucan:xyloglucosyl transferase activity                     12                                                                  

DAF: days after flowering.

Pathway-based analysis is thought to provide a basic platform for the systematic analysis of DEGs involved in metabolic or signal transduction pathways. In this study, KEGG analyses were used to analyze gene function in terms of networks of gene products. Two types of DEGs, those up and downregulated at different development stages, were classified by KEGG, respectively ([Table 6](#pone.0159723.t006){ref-type="table"}). In general, KEGG analysis assigned the DEGs (P \< 0.05) of cgy-2NIL and DN47 to 16, 3, 9, 4, and 12 metabolic pathways (each of which contained 4--175 DEGs) at 18, 25, 35, 50, and 55 DAF, respectively ([Table 6](#pone.0159723.t006){ref-type="table"}). At 18 DAF, we found several significant expression changes related to amino acid metabolism and fatty acid metabolism, including 13 genes involved in beta-alanine metabolism, six genes involved in histidine metabolism, 12 genes involved in arginine and proline metabolism, six genes involved in lysine degradation, and nine genes involved in fatty acid degradation, all of which were significantly upregulated. In addition, 41 genes involved in biosynthesis of amino acids showed significantly downregulated expression at 18 DAF. The majority of DEGs appeared to be related to 'plant-pathogen interaction' (32 genes, upregulated), 'Ribosome biogenesis in eukaryotes' (16 genes, downregulated), and 'DNA replication' (18 genes, downregulated) at 25 DAF. At 35 DAF, upregulated DEGs were assigned to 'Ribosome' and 'photosynthesis', while downregulated DEGs were assigned to seven KEGG pathways (protein processing in endoplasmic reticulum, ribosome biogenesis in eukaryotes, spliceosome, endocytosis, ABC transporters, RNA transport, and ubiquitin-mediated proteolysis). The DEGs identified at 55 DAF were assigned to 12 KEGG pathways. Pathways such as ribosome (145 genes, upregulated), biosynthesis of amino acids (114 genes, downregulated), and carbon metabolism (122 genes, downregulated) were highly represented.

10.1371/journal.pone.0159723.t006

###### Kyoto Encyclopedia of Genes and Genomes (KEGG) assignment of differentially expressed genes (DEGs) identified in five developmental stages.
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  *cgy-2*NIL\>DN47                              Number of DEGs   Corrected P-value                                                               
  --------------------------------------------- ---------------- ------------------- ---- ---- ----- ---------- ---------- ---------- ---------- ----------
  Circadian rhythm---plant                      19               \-                  \-   \-   26    1.51E-11              \-         \-         2.15E-02
  beta-Alanine metabolism                       13               \-                  \-   \-   \-    1.28E-06   \-         \-         \-         \-
  Fatty acid degradation                        9                \-                  \-   \-   25    4.49E-04   \-         \-         \-         2.15E-02
  Histidine metabolism                          6                \-                  \-   \-   \-    5.34E-04   \-         \-         \-         \-
  Arginine and proline metabolism               12               \-                  \-   \-   \-    7.32E-04   \-         \-         \-         \-
  Lysine degradation                            6                \-                  \-   \-   \-    2.26E-03   \-         \-         \-         \-
  Plant-pathogen interaction                    \-               32                  \-   \-   \-    \-         5.06E-09   \-         \-         \-
  Ribosome                                      \-               \-                  96   \-   145   \-         \-         4.64E-24   \-         2.07E-09
  Photosynthesis                                \-               \-                  41   5    \-    \-         \-         3.07E-19   2.86E-02   \-
  Protein processing in endoplasmic reticulum   \-               \-                  \-   20   77    \-         \-         \-         3.79E-10   1.89E-02
  Photosynthesis---antenna proteins             \-               \-                  \-   4    \-    \-         \-         \-         3.46E-03   \-
  Spliceosome                                   \-               \-                  \-   \-   81    \-         \-         \-         \-         4.27E-06
  Peroxisome                                    \-               \-                  \-   \-   40    \-         \-         \-         \-         2.00E-03
  RNA transport                                 \-               \-                  \-   \-   62    \-         \-         \-         \-         2.74E-03
  Sulfur relay system                           \-               \-                  \-   \-   9     \-         \-         \-         \-         2.15E-02
  Valine, leucine and isoleucine                \-               \-                  \-   \-   23    \-         \-         \-         \-         2.40E-02
  degradation                                                                                                                                    
  Carotenoid biosynthesis                       \-               \-                  \-   \-   18    \-         \-         \-         \-         3.59E-02
  ***cgy-2*NIL\<DN47**                                                                                                                           
  Ribosome                                      175              \-                  \-   \-   \-    8.27E-59   \-         \-         \-         \-
  Protein processing in endoplasmic reticulum   59               \-                  35   \-   \-    7.90E-08   \-         1.56E-02   \-         \-
  Ribosome biogenesis in eukaryotes             27               16                  35   \-   \-    2.26E-04   4.96E-07   3.02E-10   \-         \-
  DNA replication                               18               18                  \-   12   \-    5.37E-03   4.85E-11   \-         2.18E-07   \-
  Carbon fixation in photosynthetic organisms   20               \-                  \-   \-   \-    7.56E-03   \-         \-         \-         \-
  Glycolysis / Gluconeogenesis                  28               \-                  \-   \-   \-    3.02E-02   \-         \-         \-         \-
  Photosynthesis---antenna proteins             8                \-                  \-   \-   \-    3.45E-02   \-         \-         \-         \-
  Taurine and hypotaurine metabolism            7                \-                  \-   \-   \-    4.26E-02   \-         \-         \-         \-
  Plant-pathogen interaction                    34               \-                  \-   \-   \-    4.57E-02   \-         \-         \-         \-
  Biosynthesis of amino acids                   41               \-                  \-   \-   114   4.92E-02   \-         \-         \-         3.09E-02
  Spliceosome                                   \-               \-                  55   \-   \-    \-         \-         1.02E-12   \-         \-
  Endocytosis                                   \-               \-                  29   \-   \-    \-         \-         3.12E-03   \-         \-
  ABC transporters                              \-               \-                  10   \-   \-    \-         \-         8.22E-03   \-         \-
  RNA transport                                 \-               \-                  28   \-   \-    \-         \-         8.22E-03   \-         \-
  Ubiquitin-mediated proteolysis                \-               \-                  22   \-   \-    \-         \-         4.35E-02   \-         \-
  Carbon metabolism                             \-               \-                  \-   \-   122   \-         \-         \-         \-         1.18E-02

DAF: days after flowering.

Transcription factors (TFs) affected by the 'α-null' mutation {#sec014}
-------------------------------------------------------------

TFs are important proteins that control the flow of genetic information from DNA to RNA, and ultimately affect the growth and physiology of the plant. In the present study, 74 TFs were differentially expressed between *cgy-2-*NIL and DN47, when a fold change ≥ 1 and P \< 0.05 were used as cutoff values ([Table 7](#pone.0159723.t007){ref-type="table"}). These genes were divided into different classes, as shown in [Table 7](#pone.0159723.t007){ref-type="table"}. These TFs included BREVIS RADIX, GRAS, jumonji, GATA, SBP-box, and TCP. The most abundant TF group was GRAS. Among all the identified GRAS TFs, four (Glyma06G41500, Glyma07G39650, Glyma12G34420, and Glyma13G36120) were downregulated at 18 DAF in *cgy-2-*NIL; however, nine GRAS TFs were significantly upregulated at 25 DAF in *cgy-2-*NIL. Only one GRAS TF, Glyma12G34420, was identified as upregulated at 35 DAF. Eighteen GRAS TFs that were differentially expressed at 55 DAF displayed different expression patterns: 11 were downregulated in *cgy-2-*NIL, while seven were upregulated. The 55 DAF stage was characterized by the highest number of differentially expressed TFs in *cgy-2-*NIL compared with DN47, and there were more downregulated than upregulated TFs (39 *vs*. 20). Notably, 13 MADS-box TFs were all downregulated at 55 DAF. By contrast, the fewest number of TF genes was found at 50 DAF; only one upregulated TF, TCP (Glyma03G02090) and one downregulated TF, GATA (Glyma04G01090) were identified. In addition, we observed that in the 35 DAF whole seed, five groups of TFs were differentially expressed, including BREVIS RADIX (Glyma09G34601 and Glyma16G17590), GRAS (Glyma12G34420), jumonji (Glyma09G34040) and SBP-box (Glyma04G37391).

10.1371/journal.pone.0159723.t007

###### Summary and annotation of transcription factors (TFs) selected using RPKM analysis of RNA-seq data.
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  Category of TF      Gene ID                                      Gene Annotation                                                 RPKM                                                              
  ------------------- -------------------------------------------- --------------------------------------------------------------- ------- ------- ------- ------- ------ -- ------- ------- ------- -------
  BREVIS RADIX        GLYMA09G07930                                Transcription factor BREVIS RADIX                                                                                         1.69    0.68
  GLYMA09G34601                                                                                                                                    8.68    15.39                                     
  GLYMA16G17590                                                                                                                                    1.20    2.27                                      
  GRAS                GLYMA01G18040                                Transcription factor GRAS                                                                                                 0.98    3.89
  GLYMA01G33270                                                                                                                                                              0.61    1.54            
  GLYMA01G40180                                                                                                                                                              2.02    1.03            
  GLYMA01G43620                                                                                                                                                              2.02    1.03            
  GLYMA02G46730                                                                                                                    3.63    1.34                                                      
  GLYMA03G03760                                                                                                                                                              2.36    5.89            
  GLYMA04G42090                                                                                                                                                              0.81    2.61            
  GLYMA05G03490                                                                                                                    17.29   7.03                                                      
  GLYMA06G11610                                                                                                                                                              1.87    0.73            
  GLYMA06G41500       0.59                                         1.61                                                            3.37    1.28                                                      
  GLYMA07G39650       9.40                                         25.91                                                           30.06   13.50                                                     
  GLYMA08G43780                                                                                                                                                              0.75    4.82            
  GLYMA09G01440                                                                                                                    8.48    2.97                                                      
  GLYMA09G04110                                                                                                                                                              0.12    1.41            
  GLYMA10G37640                                                                                                                                                              8.87    4.01            
  GLYMA11G01850                                                                                                                                                              0.32    1.00            
  GLYMA11G14710                                                                                                                                                              0.45    1.56            
  GLYMA11G17490                                                                                                                                                              1.37    3.51            
  GLYMA12G02060                                                                                                                                                              4.05    1.82            
  GLYMA12G06670                                                                                                                                                              0.48    1.29            
  GLYMA12G16750                                                                                                                    2.80    0.71                                                      
  GLYMA12G34420       4.02                                         12.13                                                                           18.78   5.28              97.64   24.52           
  GLYMA13G09220                                                                                                                                                                                      
  GLYMA13G36120       11.15                                        26.56                                                           46.00   20.59                                                     
  GLYMA15G12320                                                                                                                    3.05    1.35                                                      
  GLYMA17G14030                                                                                                                    20.78   8.61                                                      
  GLYMA18G45220                                                                                                                                                              1.09    4.16            
  GLYMA20G30150                                                                                                                                                              21.61   7.71            
  IIc                 GLYMA14G24776                                Transcription factor IIIC, 90kDa subunit, N-terminal                                                                      6.27    2.53
  GLYMA19G40560       Transcription factor, WRKY group IIc                                                                                                                           0.97    2.62    
  jumonji, JmjN       GLYMA10G35350                                Transcription factor jumonji, JmjN                                                                                        7.92    4.35
  GLYMA09G34040       Transcription factor jumonji, JmjN                                                                                                   2.64    4.91                              
  MYC/MYB             GLYMA06G04550                                Transcription factor MYC/MYB N-terminal                                                                                   0.21    2.21
  GLYMA17G31537                                                                                                                                                              4.00    1.87            
  TFIIE               GLYMA05G38060                                Transcription factor TFIIE beta subunit,                                                                                  22.66   11.71
  GLYMA05G07910       Transcription factor TFIIE, alpha subunit                                                                                                                      8.06    3.81    
  GATA                GLYMA04G01090                                Transcription factor, GATA, plant                                               16.26   7.06              0.33    1.86            
  GLYMA10G35470                                                                                                                                                              0.84    2.57            
  GLYMA16G27171                                                                                                                                                              0.74    5.79            
  K-box MADS-box      GLYMA01G08130                                Transcription factor, K-box                                                                                               1.64    3.87
  GLYMA02G13401                                                                                                                                                              0.76    1.87            
  GLYMA04G43640                                                                                                                                                              7.40    20.22           
  GLYMA05G07286                                                                                                                                                              0.12    1.98            
  GLYMA06G48270                                                                                                                                                              8.24    24.63           
  GLYMA08G42300                                                                                                                                                              15.20   39.28           
  GLYMA11G16105                                                                                                                                                              0.16    2.52            
  GLYMA11G36890                                                                                                                                                              0.73    2.89            
  GLYMA13G06730                                                                                                                                                              5.30    17.27           
  GLYMA13G29510                                                                                                                                                              0.81    2.07            
  GLYMA14G03100                                                                                                                                                              2.01    5.78            
  GLYMA18G12590                                                                                                                                                              1.36    5.20            
  GLYMA19G04320                                                                                                                                                              16.72   53.88           
  NFYB/HAP3CBF/NF-Y   GLYMA09G01650                                Transcription factor, NFYB/HAP3Transcription factor, CBF/NF-Y                                                             0.62    2.99
  GLYMA10G05606                                                                                                                                                              20.68   9.31            
  GLYMA17G00950                                                                                                                                                              0.61    4.26            
  SBP-box             GLYMA02G13371                                Transcription factor, SBP-box                                                                                             0.36    1.07
  GLYMA03G27195                                                                                                                                                              0.36    1.07            
  GLYMA04G37391                                                                                                                                    0.25    1.48                                      
  TCP                 GLYMA03G02090                                Transcription factor, TCP                                                                                 1.23    0.24    0.06    0.40
  GLYMA05G00300                                                                                                                                                              1.74    4.07            
  GLYMA05G01131                                                                                                                                                              2.81    0.79            
  GLYMA10G06515                                                                                                                                                              5.30    2.02            
  GLYMA12G28970                                                                                                                                                              0.46    2.65            
  GLYMA12G35720                                                                                                                                                              2.40    5.57            
  GLYMA18G50371                                                                                                                                                              3.55    1.60            
  DELLA GRAS          GLYMA11G33720                                Transcription factor DELLA, N-terminal                                                                                    4.34    17.33
  GLYMA18G04500                                                                                                                                                              4.45    14.14           
  Others              GLYMA11G14450                                Transcription factor IIA, alpha/beta subunit, N-terminal                                                                  46.38   23.63
  GLYMA03G28000       Transcription factor IIS, N-terminal                                                                                                                           14.76   6.34    
  GLYMA19G31830       Transcription factor TFIIB, conserved site                                                                                                                     3.55    1.00    
  GLYMA13G07720       Transcription factor, MADS-box                                                                                                                                 0.26    1.02    

RPKM: reads per kilobase of transcript per million reads mapped; DAF: days after flowering.

Gene models annotated as Cupin proteins {#sec015}
---------------------------------------

Previous studies have characterized the cupins as important allergens in peanuts and soybeans \[[@pone.0159723.ref038]--[@pone.0159723.ref040]\]. The majority of cupin allergens belong to either the 11S legumin-like or the 7S vicilin-like seed storage globulin families. To better characterize the effect of α-null mutations on the differential expression of allergen genes, particular attention was paid to the cupin protein family in *cgy-2-*NIL. In the present study, 18 genes in [Table 8](#pone.0159723.t008){ref-type="table"} are annotated as encoding cupin proteins. In general, these genes showed peak expression (in RPKM) at 35 or 50 DAF, with RPKMs ranging from 0 to 52124.19. Most of these cupin genes were downregulated in *cgy-2-*NIL compared with DN47 throughout the five development stages.

10.1371/journal.pone.0159723.t008

###### Summary of differentially expressed genes (DEGs) annotated as Cupin proteins.

![](pone.0159723.t008){#pone.0159723.t008g}

  CUPIN DEGs                       RPKM                                                                                                                                                               
  --------------- ---------------- ---------- ---------- --------- ----------- ----------- --------- ------------ ------------ --------- ------------ ------------ --------- ----------- ------------ ---------
  GLYMA10G39150   7S(αˊ-subunit)   1.1597     1.7119     -0.6044   3398.4610   7830.8560   -1.3112   18998.7400   18363.3300   -0.0982   12163.3200   12909.6100   -0.1835   1283.1920   4885.0200    -1.7435
  GLYMA20G28650   7S(α-subunit)    0.0000     0.0075     \#        2.0333      51.8679     -4.7708   6.1619       90.2581      -4.0533   4.6006       37.4387      -3.1152   0.1290      9.2461       -5.9973
  GLYMA20G28660   7S(α-subunit)    0.0000     0.0000     \#        0.0265      15.7801     -9.3200   0.1392       91.3088      -9.4945   0.0825       35.4523      -8.8458   0.0000      1.2569       \#
  GLYMA20G28460   7S(β-subunit)    0.0000     0.0000     \#        0.0904      0.5778      -2.8160   291.5820     160.9376     0.6753    1082.1720    718.6699     0.5156    113.0759    508.6404     -1.9759
  GLYMA20G28640   7S(β-subunit)    0.0786     0.0721     0.0725    0.2241      3.2988      -3.9921   500.7281     371.2632     0.2595    1258.4940    1091.4660    0.1226    158.1022    606.8583     -1.7488
  GLYMA10G03390   7S               1.1380     1.6587     -0.5859   1095.8900   2584.6960   -1.3444   5619.9860    6335.0460    -0.3204   4041.8420    4589.9470    -0.2679   601.9122    3318.1880    -2.2761
  GLYMA02G16440   7S               0.7838     0.6071     0.3265    73.8799     260.0706    -1.9291   1747.4270    1922.5170    -0.2792   1811.1770    1356.9570    0.3192    645.7540    586.5564     0.3266
  GLYMA10G39170   7S               0.3624     0.3954     -0.1708   47.1786     122.0998    -1.4848   637.6302     734.9372     -0.3510   1636.7760    1094.2250    0.4743    1568.4520   1781.4970    0.0035
  GLYMA03G32030   11S(Gy1)         0.0090     0.0887     -3.3269   1519.8480   6668.6300   -2.2490   26382.6200   35866.6200   -0.5813   46783.7600   52124.1900   -0.2404   1808.5410   16498.6800   -2.9965
  GLYMA03G32020   11S(Gy2)         0.0140     0.0342     -1.3358   734.0615    3416.8350   -2.3344   16533.9400   21521.1000   -0.5223   33946.0400   36257.4200   -0.1794   1675.7170   11668.7100   -2.6104
  GLYMA19G34780   11S(Gy3)         0.0185     0.0341     -0.9092   20.3979     38.4533     -1.0454   4697.7480    4131.7350    0.0606    6783.2350    6454.2300    -0.0397   26.6057     260.1870     -3.1019
  GLYMA10G04280   11S(Gy4)         0.0000     0.0506     \#        188.9422    1070.9180   -2.6277   14273.1500   18260.9700   -0.4876   18121.2500   21300.1900   -0.3150   429.2719    4996.3280    -3.3479
  GLYMA13G18450   11S(Gy5)         0.0000     0.0253     \#        93.8437     526.5713    -2.6155   12032.5500   14774.3600   -0.4303   20977.4600   22500.2000   -0.1946   412.3518    4566.2670    -3.2790
  GLYMA19G34770   11s(Gy7)         0.2984     0.1888     0.6230    1.8343      1.5277      0.1746    6.6207       5.0027       0.2368    13.16456     6.525997     0.9375    20.80936    17.72077     0.4226
  GLYMA08G13440   11S              1.5047     1.5675     -0.1020   6.7538      7.3609      -0.2235   33.4617      43.2815      -0.5304   9.6622       11.0915      -0.2635   0.6632      2.7409       -0.7581
  GLYMA15G04710   11S              120.6579   102.0619   0.1985    75.7392     75.3835     -0.0973   62.8506      43.7549      0.3594    21.5767      19.7137      0.0468    3.9780      7.8482       -0.4931
  GLYMA16G00980                    0.4581     0.2641     0.7496    1.6147      1.3215      0.1921    5.8274       2.7490       0.9221    0.0588       0.1320       -1.2224   0.0000      0.0602       \#
  GLYMA10G39161                    0.0971     0.0990     -0.0746   0.1682      0.3765      -1.2215   2.4629       0.5772       1.9352    0.7714       0.0000       \#        0.0849      0.0495       0.9501

Shadowing indicates a significant change in gene expression between '*cgy-2* NIL' and 'DN47'. RPKM: reads per kilobase of transcript per million reads mapped; DAF: days after flowering. \#: One of the data is zero, cannot use multiple expression.

Among the 18 cupin genes, five belong to the β-conglycinin subunit gene family, including Glyma10g39150 encoding the α′-subunit, whereas Glyma20g28460 and Glyma20g28640 encode the β-subunit, and Glyma20g28650 and Glyma20g28660 encode the α-subunit \[[@pone.0159723.ref041]\] (<http://www.Phytozome.net/soybean>) ([Table 8](#pone.0159723.t008){ref-type="table"}). The expression of α′-subunit gene (Glyma10g39150) was detected at 18 DAF, which is earlier than both the α-and β-subunit genes and peaked at 35 DAF. Its RPKM level was much higher than both the α- and β-subunit genes during the five developmental stages. Glyma10g39150 (α′-gene) showed downregulated expression throughout the five development stages in *cgy-2-*NIL ([Table 8](#pone.0159723.t008){ref-type="table"}). Notably, the α-null mutation was associated with significantly reduced expression of both α-subunit genes, Glyma20G28650 and Glyma20G28660, in proportional amounts. The expression level of Glyma20g28650 was consistently higher than Glyma20G28660 from 25 to 55 DAF in *cgy-2-*NIL. The two genes showed almost no expression at 18 DAF, and began to be highly expressed at 25 DAF, showing peak expression at 35 DAF, which then declined until 55 DAF in DN47. Similar expression patterns of Glyma20G28650 and Glyma20G28660 were found in *cgy-2-*NIL; however, the level of expression of Glyma20G28650 was much lower in *cgy-2-*NIL than in DN47 at the same stage, while Glyma20G28660 was barely expressed throughout the five developmental stages in *cgy-2-*NIL. The two β-subunit genes of β-conglycinin, Glyma20g28460 and Glyma20g28640, also showed different expression levels between *cgy-2-*NIL and DN47. The expression levels of Glyma20g28460 and Glyma20g28640 in *cgy-2-*NIL were lower than those in DN47 at 25 DAF (by 2.8160-fold and 3.9921-fold, respectively), and at 55DAF (by 1.9759- and 1.7488-fold, respectively); However, in the other stages (35 and 50 DAF), the two β-subunit genes in *cgy-2-*NIL showed higher expression (Log2 fold change from 0.1226 to 0.6753) than in DN47.

In addition, another six differentially expressed gene IDs matched glycinin subunit genes *Gy1-7* (Glyma03g32030 to *Gy1*, Glyma03g32020 to *Gy2*; Glyma19g34780 to *Gy3*; Glyma10g04280 to *Gy4*; Glyma13g18450 to *Gy5*; Glyma19g34770 to *Gy7*) \[[@pone.0159723.ref042]--[@pone.0159723.ref044]\]. Among these six genes, the expressions of *Gy1*, *Gy2*, *Gy4*, and *Gy5* in *cgy-2*-NIL were all lower than that in DN47 throughout five developing stages, and these genes showed a similar pattern of expression, i.e., starting at about 18--25 DAF, showing a peak in RPKM at 50 DAF, and then declining rapidly thereafter ([Table 8](#pone.0159723.t008){ref-type="table"}). The expression level of *Gy3* in *cgy-2-NIL* was lower than that in DN47 at 18, 25, and 55 DAF, but higher at 35 and 50 DAF. *Gy7* expression was drastically lower than the other five glycinin genes, both in *cgy-2-NIL* and DN47 from 25 DAF to 55 DAF. Furthermore, *cgy-2-NIL* had higher expression levels of *Gy7* than that in DN47 throughout the five stages examined in the present study.

qRT-PCR validation of differential gene expression in *cgy-2-*NIL and DN47 {#sec016}
--------------------------------------------------------------------------

We used qRT-PCR to validate selected DEGs identified from the RNA-seq data. Six DEGs (GLYMA06G02690, GLYMA07G39650, GLYMA11G33720, GLYMA12G34420, GLYMA18G04500 and GLYMA20G28530) that were differentially expressed in all five stages were selected, which included up- and downregulated genes between *cgy-2-*NIL and DN47. The relative expression changes of the selected genes are shown in [Fig 3](#pone.0159723.g003){ref-type="fig"}: a positive correlation (R^2^ = 0.6069) between the RNA-seq data and qRT-PCR data was detected ([Fig 3B](#pone.0159723.g003){ref-type="fig"}). All six selected genes showed consistent up or downregulated expression patterns throughout all five detected stages, respectively, confirming the RNA-seq data ([Fig 3C](#pone.0159723.g003){ref-type="fig"}).

Discussion {#sec017}
==========

The α-subunit is one of the major components of soybean seed storage proteins; therefore, the complete deficiency of the α-subunit should change the gene' expression profiles and metabolic pathways during seed maturation. NILs are valuable genetic resources to identify genomic regions and alleles responsible for trait variation \[[@pone.0159723.ref045]\], and are also particularly suitable for genetic analyses of transcriptome and proteome variations. To further understand the potential mechanisms involved in the regulation of the α-null mutation, we have used RNA-seq to investigate global gene expression changes over five stages of soybean cotyledon development in seeds of α-subunit-deficient NIL lines (*cgy-2-*NIL). We have identified several critical genes that were possibly associated with the α-null mutation. Only Glyma20G28660 was annotated as the α-subunit gene of β-conglycinin, and appeared to be significantly downregulated throughout the three green stages (25, 35, and 50 DAF) of development studied here. Surprisingly, at 55 DAF (the desiccating stage of development), the number of DEGs was the highest. This observation is consistent with the results of a previous report \[[@pone.0159723.ref026]\], in which many genes showed peak expression at the latter stages of seed maturation. These genes were annotated as being TFs or related to protein degradation \[[@pone.0159723.ref026]\]. Our analyses have also resulted in the identification of interesting late expressed DEGs (at 55 DAF). In particular, Glyma16G03600, which is involved in cysteine and methionine metabolism, was upregulated by 7.56-fold in '*cgy-2-*NIL', and Glyma04G02660 and Glyma06G02690, which were annotated as gibberellin-regulated protein genes. We also predicted many novel candidate genes that were associated with the α-null mutation, which provide a strong basis for future research on determining the molecular mechanism of α-subunit-null deficiency. To determine whether the differential expression of genes such as Glyma16G03600, Glyma04G02660, and Glyma06G02690 have a direct relation to α-subunit-null mutation, the function of these DEGS will be studied by RNA interference or by overexpression in transgenic plants in the future. This could lead to a better understanding of the molecular regulation of storage protein subunit accumulation in the α-null mutant.

The cupins are a large superfamily, named on the basis of a conserved 'double-stranded *β*-helix' barrel-like structure ('*cupa*' means 'small barrel' in Latin). The majority of cupin allergens were originally discovered using a conserved motif found within the 7S vicilin-like or 11S legumin-like seed storage globulin families from higher plants \[[@pone.0159723.ref046]\]. The cupin superfamily of proteins possesses remarkable functional diversity, with representatives found in the Archaea, Eubacteria, and Eukaryota \[[@pone.0159723.ref047]--[@pone.0159723.ref049]\]. Previous studies characterized the majority of cupin allergens as belonging to either the 11S legumin-like or 7S vicilin-like seed storage globulin families. In our study, 16 storage protein subunit genes, eight 7S-related subunits, and eight 11S-related subunits were included in the cupin group ([Table 8](#pone.0159723.t008){ref-type="table"}).

Soybean seeds contain between 35 and 45% protein on a dry weight basis, of which about 70% consists of the two major storage proteins, 7S globulin (β-conglycinin) and 11S (glycinin). Development changes in the synthesis of β-conglycinin and glycinin have been described previously \[[@pone.0159723.ref050],[@pone.0159723.ref025],[@pone.0159723.ref026]\]. In the present study, the expression of various subunit gens of β-conglycinin and glycinin in both *cgy-2*-NIL and DN47 showed similar developmental expression patterns: they presented a bell-shaped pattern of expression that started at 18--25 DAF, reached a maximum at 35 DAF or 50 DAF, and declined rapidly thereafter. The α′-and α-subunit genes of β-conglycinin reached their expression peaks (at 35 DAF) before the β-subunit genes of β-conglycinin and five glycinin, *Gy1*--*Gy5* subunit genes (at 50 DAF). These results were similar to earlier observations \[[@pone.0159723.ref050], [@pone.0159723.ref025], [@pone.0159723.ref026]\]. However, the expression levels of 18 cupin genes in *cgy-2*-NIL were significantly different to those in DN47. The α-null mutation caused almost all the β-conglycinin (α′-, α-, and β-subunit) genes and glycinin (Gy1-, Gy2-, Gy3-, Gy4-, Gy5-, -subunits) genes to show downregulated expression in at least two stages of development studied here. The expressions of various β-conglycinin and glycinin subunit genes were regulated coordinately in the *cgy-2*-NIL, which might be responsible for the altered amino acid composition and improved protein quality.

Previous analysis of β-conglycinin-deficient lines revealed that the loss of β-conglycinin was compensated for by an increase in the abundance of glycinin \[[@pone.0159723.ref001]\]. Glycinin, an 11S globulin, is the predominant seed storage protein in soybean, and makes an important contribution to the nutritional quality of soy protein. In the present study, compared with DN47, the α-null mutation caused glycinin *Gy3* to be upregulated at 35 DAF and *Gy7* was upregulated throughout all five stages. To date, five glycinin genes, *Gy1*--*Gy5* have been described in detail. *Gy4* and *Gy5* encode proteins that have lower concentration of sulfur amino acids than the proteins derived from *Gy1*, *Gy2*, and *Gy3* \[[@pone.0159723.ref051]\]. Furthermore, Belinson et al. \[[@pone.0159723.ref044]\] identified and mapped a new functional glycinin gene, *Gy7*, which encodes the sixth glycinin subunit Gy7. Their data revealed that the steady-state amount of mRNA encoding Gy7 at seed mid-maturation is an order of magnitude less than the mRNA encoding the five other glycinin subunits \[[@pone.0159723.ref044]\]. Similar results were obtained in our study, which further confirmed that the *GY7* gene has a lower expression level than the five other glycinin subunits from 25 to 55 DAF, both in *cgy-2-*NIL and DN47. To date, little is known about the effect of the Gy7 subunit on protein nutritional quality, tofu-making quality, and its health benefits. Different from the other five glycinin genes, *GY7* expression in *cgy-2-*NIL slightly exceeded that of DN47 throughout the five stages identified in the present study, and showed a unique developmental expression pattern in both *cgy-2-*NIL and DN47, i.e., increased from the 18 DAF until reaching a peak at 55 DAF. The upregulated expressions of *Gy3* and *Gy7* might, at least in part, contribute to the modified final seed protein content in *cgy-2*-NIL.

Conclusions {#sec018}
===========

We present an overview of genes whose expression was affected by the 'α-null' mutation in soybeans. A number of soybean genes with annotations related to cupin allergen proteins, transcription factors, and other processes were differentially expressed in *cgy-2-*NIL. Some of these genes may be candidates for hypoallergenic soybean breeding. The *cgy-2* allele in the homozygous form modified the expression level of various β-conglycinin and glycinin cupin-family-genes. The desiccating stage of development (55DAF), is a critical period of differential gene expression. Our findings will help provide a detailed understanding of the α-subunit-null mechanism. In addition, the *cgy-2* allele was validated as an effective and useful allele for soybean breeding programs that aim to modify protein quality and reduce allergenicity.

The work was supported by the National Natural Science Foundation of China (31071440 and 31371650) and the Northeast Agricultural University Innovation Foundation for Postgraduates (yjscx14042). The study is part of the PhD research of the first author.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: **Conceived and designed the experiments:** SSL.**Performed the experiments:** BS LXA YJH HXG HBR XZ HBK.**Analyzed the data:** SSL BS XZ XSW YJH.**Contributed reagents/materials/analysis tools:** BS HBK YJH XZ HXG HBR XSW.**Wrote the paper:** SSL HBK BS.
